Skip to main content


Placeholder slot

This page contains brief information about trastuzumab (Herceptin, Ogivri, Herzuma) and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at DailyMed.

Use in Cancer

Trastuzumab is approved to be used alone or with other drugs to treat:

Trastuzumab is also available in a different form, combined with hyaluronidase. For more information, see the Drug Information Summary for Trastuzumab and Hyaluronidase-oysk.

Trastuzumab is also being studied in the treatment of other types of cancer.

More About Trastuzumab

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Trastuzumab - A lay language summary of important information about this drug that may include the following:

  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Research Results and Related Resources

For Metastatic HER2-Positive Breast Cancer, New Treatments Emerge

Monoclonal Antibodies

Biosimilars for Cancer Emerge as Patents on Widely Used Biological Drugs Expire

Higher Risk of Heart Failure Seen in Some Cancers

Two Drugs That Hit One Target Improve Survival in Women with Metastatic Breast Cancer

Targeted Cancer Therapies

For Some Breast Cancers, New Drug May Be Treatment Option

Chemotherapy Less Toxic to the Heart May Be Option for Some Women with HER2-Positive Breast Cancer

The ALTTO Breast Cancer Trial

Trastuzumab after Chemotherapy Is Effective in HER2-Positive Breast Cancer

Clinical Trials Accepting Patients

Find Clinical Trials for Trastuzumab - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: